Kuo CJ et al. |
Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. |
1992 |
Nature |
pmid:1614535
|
Sampson BA and Gotschlich EC |
Neisseria meningitidis encodes an FK506-inhibitable rotamase. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1371354
|
Andersson J et al. |
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. |
1992 |
Immunology |
pmid:1371491
|
Strasser S et al. |
Effect of FK506 on insulin secretion in normal dogs. |
1992 |
Metab. Clin. Exp. |
pmid:1371575
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Matsuura T et al. |
Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro. |
1992 |
Transplant. Proc. |
pmid:1371623
|
Moutabarrik A et al. |
In vitro FK506 kidney tubular cell toxicity. |
1992 |
Transpl. Int. |
pmid:14621743
|
Okamura N et al. |
Enhanced liver regeneration by FK 506 can be blocked by interleukin-1 alpha and interleukin-2. |
1992 |
Transplant. Proc. |
pmid:1371624
|
Moutabarrik A et al. |
FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells. |
1992 |
Transpl. Int. |
pmid:14621744
|
Sakr M et al. |
Effect of renal ischemia on plasma levels of FK 506 in rats. |
1992 |
Transplant. Proc. |
pmid:1371625
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Ochiai T |
[Advances in the fundamentals and therapeutic use of immunosuppressive agents]. |
1992 |
Arerugi |
pmid:1374229
|
Hung DT and Schreiber SL |
cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1374240
|
Jayaraman T et al. |
FK506 binding protein associated with the calcium release channel (ryanodine receptor). |
1992 |
J. Biol. Chem. |
pmid:1374404
|
Höllsberg P et al. |
Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. |
1992 |
J. Immunol. |
pmid:1374452
|
Schreiber SL and Crabtree GR |
The mechanism of action of cyclosporin A and FK506. |
1992 |
Immunol. Today |
pmid:1374612
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Graeb C et al. |
Cytoimmunologic monitoring of small bowel allograft recipients. |
1992 |
Transplant. Proc. |
pmid:1376515
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Hatazawa C et al. |
Effect of FK 506 on bowel transplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376517
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Masutani H et al. |
Suppression of the histologic changes of GVHD by FK 506 in rat small bowel transplantation. |
1992 |
Transplant. Proc. |
pmid:1376519
|
Santiago SF et al. |
Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376520
|
Utsunomiya H et al. |
Effect of FK 506 on orthotopic small bowel transplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376521
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Yagihashi A et al. |
HLA matching effect in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1281569
|
Kobayashi M et al. |
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch. |
1992 |
Transplant. Proc. |
pmid:1281570
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Tze WJ et al. |
FK 506: an effective immunosuppressant for islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1281577
|
Kamei T et al. |
Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft. |
1992 |
Transplant. Proc. |
pmid:1281579
|
Woo J et al. |
FK 506 treatment following syngeneic bone marrow transplantation does not inhibit clonal deletion of V beta 5+ or V beta 11+ T cells. |
1992 |
Transplant. Proc. |
pmid:1281583
|
Ramamoorthy S et al. |
Selective impairment of taurine transport by cyclosporin A in a human placental cell line. |
1992 |
Pediatr. Res. |
pmid:1378960
|
Armitage JM et al. |
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. |
1992 |
Ann. Thorac. Surg. |
pmid:1379032
|
Thomson AW |
The spectrum of action of new immunosuppressive drugs. |
1992 |
Clin. Exp. Immunol. |
pmid:1379130
|
Fischer G et al. |
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. |
1992 |
Mol. Microbiol. |
pmid:1379319
|
Rondeau E |
[Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin]. |
1992 |
Nephrologie |
pmid:1379348
|
Schreiber SL |
Immunophilin-sensitive protein phosphatase action in cell signaling pathways. |
1992 |
Cell |
pmid:1379518
|
Aldape RA et al. |
Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. |
1992 |
J. Biol. Chem. |
pmid:1379588
|
Langrehr JM et al. |
Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. |
1992 |
J. Clin. Invest. |
pmid:1379617
|
Bach JF |
Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity. |
1992 |
J. Autoimmun. |
pmid:1380245
|
Baumann G et al. |
Molecular mechanisms of immunosuppression. |
1992 |
J. Autoimmun. |
pmid:1380246
|
Walpoth B et al. |
Assessment of new immunosuppressive drugs in a rat cardiac allograft heterotopic model. |
1992 |
Eur Surg Res |
pmid:1380460
|
Petros AM et al. |
Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR. |
1992 |
FEBS Lett. |
pmid:1380470
|
Van Thiel DH et al. |
FK 506 reduces the injury experienced following renal ischemia and reperfusion. |
1992 |
Ren Fail |
pmid:1380720
|
Bolton C |
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE). |
1992 |
Agents Actions |
pmid:1380765
|
Terada N et al. |
Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1380801
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Meiser BM et al. |
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. |
1992 |
Transplant. Proc. |
pmid:1384201
|
Wakabayashi H et al. |
Effect of FK 506 and cyclosporine A on hepatic energy status in the rat after warm ischemia, as monitored by 31P nuclear magnetic resonance spectroscopy in vivo. |
1992 |
Transplant. Proc. |
pmid:1384205
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Griffiths RJ et al. |
Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development. |
1992 |
Agents Actions |
pmid:1384284
|
Todo S et al. |
Intestinal transplantation in composite visceral grafts or alone. |
1992 |
Ann. Surg. |
pmid:1384443
|
Massol N et al. |
Rabbit FKBP59-heat shock protein binding immunophillin (HBI) is a calmodulin binding protein. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1384470
|
Mizuno K et al. |
Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. |
1992 Jan-Feb |
Anticancer Res. |
pmid:1373592
|
Arai S et al. |
The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine. |
1992 Jul-Aug |
J. Heart Lung Transplant. |
pmid:1379829
|
Fagiuoli S et al. |
FK 506: a new immunosuppressive agent for organ transplantation. Pharmacology, mechanism of action and clinical applications. |
1992 Jul-Aug |
Ital J Gastroenterol |
pmid:1381245
|
Tong J et al. |
Effect of FK-506 and cyclosporin A on in vitro CFU-GM growth in severe aplastic anemia patients. |
1992 Jul-Aug |
Haematologica |
pmid:1385279
|
Nazer H et al. |
FK 506 associated disorders in liver transplantation. |
1992 May-Jun |
J. Gastroenterol. Hepatol. |
pmid:1377038
|
Bowman H and Lennard TW |
Immunosuppressive drugs. |
1992 Nov 4-17 |
Br J Hosp Med |
pmid:1282440
|
Sattler M et al. |
Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. |
1992 Sep-Oct |
Drug Metab. Dispos. |
pmid:1385058
|
Tabasco-Minguillan J et al. |
Long-term insulin requirement after liver transplantation with FK 506 in American veterans. |
1993 |
Transplant. Proc. |
pmid:7679839
|
Klintmalm GB et al. |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679840
|
Gunji Y et al. |
Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443. |
1993 |
Transplant. Proc. |
pmid:7679841
|
Jayaraman T and Marks AR |
Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line. |
1993 |
J. Biol. Chem. |
pmid:7503980
|
D'Ambrosio R et al. |
Validation and quality assurance program for monitoring tacrolimus (FK 506) concentrations in plasma and whole blood. |
1993 |
Ther Drug Monit |
pmid:7504339
|
Reese JC et al. |
The effect of FK506 on canine bile flow. |
1993 |
Transplantation |
pmid:7504342
|
Valdivia LA et al. |
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. |
1993 |
Transplantation |
pmid:7681230
|
Fujimura A et al. |
Chronopharmacokinetic study of a new immunosuppressive agent, FK 506, in mice. |
1993 |
Jpn. J. Pharmacol. |
pmid:7681489
|
Nishinaka Y et al. |
Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. |
1993 |
J. Cardiovasc. Pharmacol. |
pmid:7681507
|
Mühl H et al. |
Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells. |
1993 |
Eur. J. Pharmacol. |
pmid:7506668
|
Simek SL et al. |
Sequence and localization of a novel FK506-binding protein to mouse chromosome 11. |
1993 |
Genomics |
pmid:7507077
|
Izumi S and Okuhara M |
[FK506 and kifunensine, new immunomodulators of microbial origin]. |
1993 |
Tanpakushitsu Kakusan Koso |
pmid:7692469
|
Wakugami T et al. |
Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin. |
1993 |
Tohoku J. Exp. Med. |
pmid:7692621
|
Hill CC et al. |
Penile prosthesis surgery in the immunosuppressed patient. |
1993 |
Transplantation |
pmid:7692633
|
Roberts JP et al. |
Reversal of chronic rejection after treatment failure with FK506 and RS61443. |
1993 |
Transplantation |
pmid:7692634
|
Yatscoff RW et al. |
Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro. |
1993 |
Clin. Biochem. |
pmid:7507804
|
Sato M et al. |
FK506 inhibits phytohemagglutinin-, but not interferon-gamma-, induced HLA-DR antigen expression and accessory cell function on primary cultured human thyroid cells. |
1993 |
Acta Endocrinol. |
pmid:7509103
|
Blaehr H et al. |
Acute effects of FK506 and cyclosporine A on cultured human proximal tubular cells. |
1993 |
Eur. J. Pharmacol. |
pmid:7683267
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
Kadmon M et al. |
Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. |
1993 |
Gastroenterology |
pmid:7683296
|
Denesyuk AI et al. |
Structural similarity of the binding sites of cyclophilin A-cyclosporin A and FKBP-FK506 systems. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7683466
|
Moutabarrik A et al. |
Effect of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes. |
1993 |
Transplant. Proc. |
pmid:7685949
|
Takaya S et al. |
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. |
1993 |
Transplant. Proc. |
pmid:7685953
|
Murphy MP and Morris RE |
Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model. |
1993 |
Transplant. Proc. |
pmid:7685955
|
Yamaoka K et al. |
Cyclosporin A and FK506 block the negative signaling mediated by surface IgM cross-linking in normal human mature B cells. |
1993 |
Immunol. Lett. |
pmid:7688712
|
Smith DF et al. |
Two FKBP-related proteins are associated with progesterone receptor complexes. |
1993 |
J. Biol. Chem. |
pmid:7688746
|
Jacobs JC et al. |
Pyoderma gangrenosum in infancy. |
1993 |
J. Am. Acad. Dermatol. |
pmid:7688775
|
Garrity GM et al. |
Genetic relationships among actinomycetes that produce the immunosuppressant macrolides FK506, FK520/FK523 and rapamycin. |
1993 |
J. Ind. Microbiol. |
pmid:7688970
|
Mollison KW et al. |
Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689812
|
Tai PK et al. |
P59 (FK506 binding protein 59) interaction with heat shock proteins is highly conserved and may involve proteins other than steroid receptors. |
1993 |
Biochemistry |
pmid:7689858
|
Lieberman R |
FK506, artificial intelligence and pharmacoeconomics. |
1993 |
J Clin Pharmacol |
pmid:7690045
|
Zuany-Amorim C et al. |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice. |
1993 |
Br. J. Pharmacol. |
pmid:7694762
|
Armitage JM et al. |
Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7679172
|
Ito K and Komatsu Y |
[Drug induced hemolytic uremic syndrome]. |
1993 |
Nippon Rinsho |
pmid:7679450
|
Hirasé Y et al. |
Transplantation of long-term cryopreserved allocutaneous tissue by skin graft or microsurgical anastomosis: experimental studies in the rat. |
1993 |
Plast. Reconstr. Surg. |
pmid:7679796
|
Langrehr JM et al. |
Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. |
1993 |
Transplantation |
pmid:7679526
|
Uemoto S et al. |
Experience with FK506 in living-related liver transplantation. |
1993 |
Transplantation |
pmid:7679528
|